NIH-funded research R21 grant

Understanding how SSBP1 mutations affect vision

Official title: Molecular Mechanisms Underlying the Effects of SSBP1 Mutation on Vision

Funded at Columbia University Health Sciences · NIH-11036542 · Data updated 2026-11-12

This study is looking at how a specific gene mutation affects vision in people with Optic Atrophy-13, using a special mouse model to understand how it harms retinal cells, with the goal of finding new ways to help preserve sight for those affected.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$261,550
NIH project number1R21EY037007-01
Project IDNIH-11036542 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Optic Atrophy-13 or related mitochondrial eye diseases.

Less likely to help

Patients with retinal degeneration not linked to SSBP1 mutations may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms behind retinal degeneration caused by mutations in the SSBP1 gene, which is linked to a condition known as Optic Atrophy-13. Using a novel mouse model that mimics the human condition, the study aims to explore how the R107Q variant of the SSBP1 gene impacts retinal cells and mitochondrial function. By examining the effects of this mutation, the researchers hope to uncover insights that could lead to new therapies aimed at preserving vision in affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies to prevent vision loss in patients with mitochondrial eye diseases.

How similar studies have gone: Previous research has shown promising results in understanding mitochondrial dysfunction in other genetic conditions, suggesting potential for success in this area as well.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Wang, Nan-Kai — Columbia University Health Sciences
  • Study coordinator: Wang, Nan-Kai

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.